Ubs Group Ag Agios Pharmaceuticals, Inc. Call Options Transaction History

Ubs Group Ag

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $655,744 - $1.1 Million	21,800 Added 77.3%	50,000 $2.39 Million
Q1 2017 Nov 14, 2017	BUY	N/A	28,200	28,200 $1.65 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.97B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.